.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
McKinsey
Teva
Cantor Fitzgerald
Healthtrust
Cerilliant
Baxter
Mallinckrodt
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview

ERYC Drug Profile

« Back to Dashboard

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mayne PharmaERYCerythromycinCAPSULE, DELAYED REL PELLETS;ORAL050536-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Johnson And JohnsonERYCETTEerythromycinSWAB;TOPICAL050594-001Feb 15, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Warner Chilcott LlcERYCerythromycinCAPSULE, DELAYED REL PELLETS;ORAL062338-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisERYCerythromycinCAPSULE, DELAYED REL PELLETS;ORAL062546-001Jul 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisERYCerythromycinCAPSULE, DELAYED REL PELLETS;ORAL062618-001Sep 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraERYC SPRINKLESerythromycinCAPSULE, DELAYED REL PELLETS;ORAL050593-001Jul 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisERYC 125erythromycinCAPSULE, DELAYED REL PELLETS;ORAL062648-001Oct 24, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Covington
Fuji
Harvard Business School
Argus Health
Merck
Federal Trade Commission
Novartis
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot